An enormous number of people die due to flu and its associated intricacies every year. Annual vaccination is considered to be the gold standard strategy to protect the individual from acquiring infection and further decimation, although recent estimates suggest that overall flu vaccine effectiveness was...
The following articles appeared in the print edition ofInfectious Disease News. Table of Contents
The following articles appeared in the print edition ofInfectious Disease News. Table of Contents
With 12,500 deaths in the United States in 2009-2010, the influenza (H1N1) 2009 pandemic was actually less deadly than the seasonal flu. But it essentially hit the young, and the toll calculated in years of life lost is high. The monovalent vaccines, whether live attenuated or inactivated ...
"There is no world, I think, where [the effectiveness] is the same level ... we had with [the] Delta [variant]," he told the Financial Times, while noting that that the drugmaker is still testing its vaccine on Omicron. Omicron: What we know — and don't know — about new CO...
Phase 1 safety and immunogenicity study of a quadrivalent Seasonal Flu Vaccine comprising recombinant hemagglutinin-flagellin Fusion proteins. Open Forum Infect Dis. 2016;3(1):ofw015. Article PubMed PubMed Central Google Scholar Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y,...
potential use of an mRNA vaccine against the influenza virus. In their work, they designed an mRNA for vaccination the against influenza A virus and showed protection efficacy in mice, ferrets, and domestic pigs. They also suggested that designing mRNA vaccines against the seasonal flu would be ...
This disease has similar symptoms as the flu such as fever, cough, and fatigue, which are essential to recognize for early diagnosis [11]. The incubation period of COVID-19 takes from 1 to 14 days. Surprisingly, a patient without any symptoms can possibly be a transmitter of the COVID-...
potential use of an mRNA vaccine against the influenza virus. In their work, they designed an mRNA for vaccination the against influenza A virus and showed protection efficacy in mice, ferrets, and domestic pigs. They also suggested that designing mRNA vaccines against the seasonal flu would be ...
(Kallerup and Foged2015). Until now, several inactivated vaccines have been developed and licensed such as Typhoid vaccine, AGRIFLU ® as a trivalent vaccine against influenza type A and B viruses, Havrix ® (GSK) to prevent Hepatitis A disease and IPOL ® (Sanofi Pasteur) that targets...